← 홈

ADC · 고형암 (전체)

349개 · ADC 1032 · Antibody 4683 · CGT 2713 · 다음 갱신 D-8 · 마지막 7월 21일

인기최근 업데이트큐레이션임상 많은갱신 필요ORR최신Phase 3FDA승인프로그램 349개
ADCBiologicstaleCytomX TherapeuticsPhase 2

CX-2029 (CX-2029)

Solid Tumor, Adult; Head and Neck Cancer · Solid Tumor, Adult

#SolidTumorAdult#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+4
임상시험 1상태 ACTIVE
ADCBiologicstaleDragonfly TherapeuticsPhase 2

DF1001 (DF1001)

Solid Tumor, Adult · Solid Tumor, Adult

#SolidTumorAdult#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+3
임상시험 1상태 ACTIVE
ADCBiologicstaleDaiichi SankyoPhase 1

DS-1103a (DS-1103a)

Advanced Solid Tumor · Advanced Solid Tumor

#AdvancedSolidTumor#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+1
임상시험 1상태 RECRUITING
ADCBiologicstaleHangzhou DAC Biotechnology Co.,…Phase 1

DXC006 (DXC006)

Advanced Solid Tumors; Hematological Malignancies · Advanced Solid Tumors

#AdvancedSolidTumors#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+2
임상시험 1상태 RECRUITING
ADCBiologicstaleRemeGenPreclinical

disitamab vedotin (Disitamab Vedotin, RC48, Disitamab Vedotin combined with Zimberelizumab)

Biliary Carcinoma · Biliary Carcinoma

#BiliaryCarcinoma#ADC#Preclinical#항체약물접합체#antibody-drug-conjugate+1
임상시험 1상태 ACTIVE
ADCBiologicstaleRemeGenPreclinical

disitamab vedotin (Disitamab Vedotin, RC48, Disitamab vedotin + Sintilimab + Multimodality radiotherapy)

HER2-positive Advanced Gastric Cancer or Gastroesophageal Junction Adenocarcinoma · HER2

#HER2#ADC#Preclinical#항체약물접합체#antibody-drug-conjugate+2
임상시험 1상태 RECRUITING
ADCBiologicstaleMerck Sharp & Dohme LLCPhase 2

Docetetaxel (Docetetaxel)

Carcinoma, Non-Small-Cell Lung · Carcinoma, Non-Small-Cell Lung

#CarcinomaNon-Small-CellLung#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+3
임상시험 1상태 RECRUITING
ADCBiologicstaleInnovent Biopharmaceutical Tech…Phase 1

Drug: IBI3028 (Drug: IBI3028)

Solid Tumor; Colorectal Cancer · Solid Tumor

#SolidTumor#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+2
임상시험 1상태 RECRUITING
ADCBiologicstaleEisbach Bio GmbHPhase 2

EIS-12656 (EIS-12656)

Advanced Solid Tumor; Homologous Recombination Deficiency · Advanced Solid Tumor

#AdvancedSolidTumor#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+2
임상시험 1상태 RECRUITING
ADCBiologicstaleInstitut CuriePhase 3

Endocrine therapy combined with the local treatment of FES-negative lesions (Endocrine therapy combined with the local treatment of FES-negative lesions)

Breast Carcinoma · Breast Carcinoma

#BreastCarcinoma#ADC#Phase3#항체약물접합체#antibody-drug-conjugate+1
임상시험 1상태 RECRUITING
ADCBiologicstaleShanghai Fudan-Zhangjiang Bio-P…Phase 1

FDA022 Monoclonal antibody-drug conjugate for injection Phase Ia (FDA022 Monoclonal antibody-drug conjugate for injection Phase Ia)

Advanced Solid Tumors · Advanced Solid Tumors

#AdvancedSolidTumors#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+1
임상시험 1상태 ACTIVE
ADCBiologicstaleShanghai Fudan-Zhangjiang Bio-P…Phase 1

FDA022 Monoclonal antibody-drug conjugate for injection Phase Ib (FDA022 Monoclonal antibody-drug conjugate for injection Phase Ib)

Advanced Solid Tumors · Advanced Solid Tumors

#AdvancedSolidTumors#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+1
임상시험 1상태 ACTIVE
ADCBiologicstaleShanghai Fudan-Zhangjiang Bio-P…Phase 1

FZ-AD004 (FZ-AD004)

Advanced and Metastatic Solid Tumor · Advanced and Metastatic Solid Tumor

#AdvancedandMetastaticSolidTumor#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+1
임상시험 1상태 RECRUITING
ADCBiologicstaleGenerate BiomedicinesPhase 1

GB-4362 (GB-4362)

Advanced Urothelial Cancer; Metastatic Urothelial Carcinoma · Advanced Urothelial Cancer

#AdvancedUrothelialCancer#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+2
임상시험 1상태 RECRUITING
ADCBiologicstaleChangchun GeneScience Pharmaceu…Phase 1

GenSci139 (GenSci139)

Advanced Solid Tumors · Advanced Solid Tumors

#AdvancedSolidTumors#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+1
임상시험 1상태 RECRUITING
ADCBiologicstaleHangzhou Zhongmei Huadong Pharm…Phase 1

HDM2024 (HDM2024)

Advanced Solid Tumors · Advanced Solid Tumors

#AdvancedSolidTumors#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+1
임상시험 1상태 RECRUITING
ADCBiologicstaleNovartis PharmaceuticalsPhase 1

HKT288 (HKT288)

Epithelial Ovarian Cancer; Renal Cell Carcinoma · Epithelial Ovarian Cancer

#EpithelialOvarianCancer#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+2
임상시험 1상태 DISCONTINUED
ADCBiologicstaleShanghai Henlius BiotechPhase 1

HLX42 (HLX42)

Solid Tumor and NSCLC · Solid Tumor and NSCLC

#SolidTumorandNSCLC#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+1
임상시험 1상태 RECRUITING
ADCBiologicstaleShanghai Henlius BiotechPhase 1

HLX48 (HLX48)

Advanced/Metastatic Solid Tumors · Advanced/Metastatic Solid Tumors

#AdvancedMetastaticSolidTumors#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+3
임상시험 1상태 RECRUITING
ADCBiologicstaleImmunoGen, Inc.Phase 2

IMGC936 (IMGC936)

Advanced Solid Tumor · Advanced Solid Tumor

#AdvancedSolidTumor#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+1
효능 ORR 0%임상시험 1상태 ACTIVE

13 / 18 페이지

← 이전다음 →